Muhammet Bekir Hacıoğlu

Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?

Osman Köstek, Muhammet Bekir Hacıoğlu, Abdullah Sakin et al. · Cancer Chemotherapy and Pharmacology · 2018 · 36 citations

Medicine, Oncology, Pharmacology +12

K-RAS and N-RAS mutations in testicular germ cell tumors

Muhammet Bekir Hacıoğlu, Hilmi Kodaz, Bülent Erdoğan et al. · Bosnian Journal of Basic Medical Sciences · 2017 · 28 citations · Full text

Medicine, Genetics, Oncology +15

Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib

Ali Gökyer, Ahmet Küçükarda, Osman Köstek et al. · Clinical & Translational Oncology · 2019 · 23 citations

Medicine, Oncology, Pharmacology +14

Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma

Ahmet Küçükarda, Bülent Erdoğan, Ali Gökyer et al. · Supportive Care in Cancer · 2021 · 20 citations

Medicine, Nutritional Sciences, Oncology +11

Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study

Sinan Koca, Mehmet Beşiroğlu, Melike Özçelik et al. · Journal of Oncology Pharmacy Practice · 2020 · 12 citations

Medicine, Oncology, Pharmacology +14